Ludwig Goris
Directeur/Bestuurslid bij Caloritum NV
Oorsprong van het eerstegraads netwerk van Ludwig Goris
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Capricorn Partners NV
 Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium.
30
| Private Company | Investment Managers | 30 |
ViroVet NV
 ViroVet NV Pharmaceuticals: MajorHealth Technology ViroVet NV is a Belgian company that focuses on the discovery, licensing, and development of biopharmaceutical products for livestock. The company is based in Leuven, Belgium. ViroVet was founded by Erwin Blomsma, Stefaan Wera, and Nesya Goris, with Erwin Blomsma serving as the CEO since incorporation.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Caloritum NV
 Caloritum NV Industrial ConglomeratesProducer Manufacturing Caloritum NV offers innovative technology to industrial customers. The firm provides transform wasted heat into useful process heat and reduces the total energy bill by saving fossil fuels and CO2 emissions. The company was founded by Wouter Ducheyne and Christian Heeren in 2012 and is headquartered in Antwerp, Belgium.
8
| Holding Company | Industrial Conglomerates | 8 |
c-LEcta GmbH
 c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany.
8
| Subsidiary | Biotechnology | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ludwig Goris via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| FMC CORPORATION | Chemicals: Agricultural | Corporate Officer/Principal | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Public Communications Contact | |
| QUEST FOR GROWTH NV | Investment Managers | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Investment Officer Director/Board Member | |
Goldman Sachs Investment Management (Singapore) Ltd.
 Goldman Sachs Investment Management (Singapore) Ltd. Investment ManagersFinance Goldman Sachs Investment Management (Singapore) Ltd. (GSIM Singapore) is the Singapore-based asset management subsidiary of Goldman Sachs Advisors BV, ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS), a multinational investment bank and financial services company headquartered in the US. The firm was founded in 1996 and formerly known as NN Investment Partners (Singapore) Ltd. GSIM Singapore provides investment management solutions to a diverse set of institutional and individual clients. They also manage Luxembourg-domiciled funds. | Investment Managers | President | |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Sopartec SA
 Sopartec SA Investment ManagersFinance Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
Occidental Chemical Corp.
 Occidental Chemical Corp. Chemicals: Major DiversifiedProcess Industries Occidental Chemical Corp. manufactures polyvinyl chloride resins, chlorine and caustic soda. It also offers basic chemicals, oxyvinyls, food grade and armand products. The company was founded in 1988 and is headquartered in Dallas, TX. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Avantium Technologies BV
 Avantium Technologies BV Miscellaneous Commercial ServicesCommercial Services Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
NN Investment Partners (Japan) Co., Ltd.
 NN Investment Partners (Japan) Co., Ltd. Investment ManagersFinance NN Investment Partners (Japan) Co. Ltd. (NN IP-JP) is the Japanese subsidiary of NN Investment Partners Holdings NV, ultimately held by ING Groep N.V. (NYSE: ING) in The Netherlands. NN IP-JP was established in 1999 and services Japanese institutions (governmental and corporate pension funds, insurance companies and foundations) as well as private individuals. Based in Tokyo, the firm co-advises sub-funds of umbrella funds domiciled in Europe and manages Japan-domiciled funds, focusing on the Japanese market. They also distribute the diverse range of funds managed within the parent group. | Investment Managers | President | |
Participatiemaatschappij Vlaanderen NV
 Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
ODDO BHF Corporates & Markets AG
 ODDO BHF Corporates & Markets AG Investment Banks/BrokersFinance ODDO BHF Corporates & Markets AG (ODDO BCM) is a securities trading firm headquartered in Frankfurt, Germany. The firm was founded in 1994 and became a subsidiary of France-based Oddo BHF SCA in 2015. ODDO BCM is actively involved in the capital market primarily in four areas: equities and bond trading, market making as a designated sponsor, as a floor specialist broker on the Frankfurt Stock Exchange and in Corporate Finance. It advises German and other European SMEs on all their capital market plans, particularly in the areas of capital markets. | Investment Banks/Brokers | Institutional Sales | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Indian Institute of Technology New Delhi | College/University | Undergraduate Degree | |
| ABLYNX | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| NEXSTIM PLC | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Hamburg | College/University | Doctorate Degree Doctorate Degree | |
| Delft University of Technology | College/University | Undergraduate Degree Graduate Degree | |
| Ghent University | College/University | Graduate Degree Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin | |
| Vlerick Leuven Gent Management School | College/University | Undergraduate Degree Graduate Degree | |
| Friedrich Schiller University of Jena | College/University | Undergraduate Degree | |
| Universität Leipzig | College/University | Undergraduate Degree | |
| AVANTIUM N.V. | Industrial Machinery | Chairman Director/Board Member | |
Biocleave Ltd.
 Biocleave Ltd. BiotechnologyHealth Technology Biocleave Ltd. develops and sells microbial technology for the production of renewable chemicals and biofuels. It also provides biobutanol and other C4 chemical products. The firm also engages in microbiology and metabolic engineering through fermentation and commercial production scale. Its products include biobutanol chemicals and fuel, acetone, and butyric acid. The company was founded by Edward M. Green in 2003 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
IMEC VZW /Private Equity/
 IMEC VZW /Private Equity/ Investment ManagersFinance IMEC VZW (Private Equity) (IMEC) is a operating division of Interuniversitair Micro-Electronica Centrum VZW founded in 1984. The firm is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Université Catholique de Louvain | College/University | Graduate Degree Doctorate Degree | |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Founder Director/Board Member | |
FRX Polymers, Inc.
 FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
ÖKOWORLD LUX SA
 ÖKOWORLD LUX SA Investment ManagersFinance ÖKOWORLD LUX SA (ÖKOWORLD) is the wholly-owned Luxembourg-based investment management subsidiary of ÖKOWORLD AG (FR: VVV3) in Germany. ÖKOWORLD was founded in 1995 by Alfred Platow as a pioneering ecological and ethical investment management firm. They are organized as an investment trust and manage funds which follow environmental, ethical and social criteria. ÖKOWORLD believes in following investment principles that meet the needs of present generations without compromising those of future generations. | Investment Managers | Analyst-Equity | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree | |
SABIC Ventures BV
 SABIC Ventures BV Investment ManagersFinance SABIC Ventures BV is a venture capital firm founded in 2011. The firm headquartered in Netherlands. | Investment Managers | Private Equity Investor | |
Capricorn Venture Partners NV (Investment Management)
 Capricorn Venture Partners NV (Investment Management) Investment ManagersFinance Capricorn Venture Partners NV (Investment Management) (Capricorn Partners-IM) is the investment management division of Capricorn Venture Partners NV, a private venture company headquartered in Leuven, Belgium. The firm was founded in 1993 as a joint venture between Dr. Jos B. Peeters and Baring Venture Partners Ltd. They were renamed as Capricorn Venture Partners in 2019. Capricorn Partners-IM manages private and public equity investment funds for retail and institutional investors. | Investment Managers | Chief Executive Officer Head-Equity Investments Portfolio Manager-Equities Head-Equity Investments | |
Impactassets, Inc.
 Impactassets, Inc. Insurance Brokers/ServicesFinance ImpactAssets provides insurance and financial services. The company was founded by Tim Freundlich in 2010 and is headquartered in Bethesda, MD. | Insurance Brokers/Services | Director/Board Member | |
Brightlands Venture Partners BV
 Brightlands Venture Partners BV Investment ManagersFinance Brightlands Venture Partners is an independent regional venture capital firm headquartered in Brightlands, Netherlands. The firm was founded in 2004. | Investment Managers | Private Equity Investor | |
Ancoa Software Ltd.
 Ancoa Software Ltd. Data Processing ServicesTechnology Services Ancoa Software Ltd. develops financial software. It services include AlertView provides a case management solution for investigating alerts, marketView offers a real-time dash board to markets, TradeView provides graphical view of the trading information, OrderView allows users to reconstruct and play the order book at any time, ReportView provides easy reporting capabilities and DataView provides access to the underlying market data. The company was founded by Andrew Louth and Stefan Hendrix in 2010 and is headquartered in London, the United Kingdom. | Data Processing Services | Director/Board Member Chairman | |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Frx Polymers NV
 Frx Polymers NV Chemicals: SpecialtyProcess Industries Frx Polymers NV is a Belgian company that manufactures and supplies homopolymers, copolymers, and oligomers. The private company is based in Antwerp, Belgium. | Chemicals: Specialty | Director/Board Member | |
Newton Biocapital Partners SRL
 Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre. | Investment Managers | Private Equity Investor | |
Qpinch BV
 Qpinch BV Information Technology ServicesTechnology Services Qpinch BV provides heat recovery technology solutions. The company is based in Antwerp, Belgium. Wouter Ducheyne, Christian Heeren has been the CEOs since 2012. The Belgian company was founded in 2012 by Wouter Ducheyne, Christian Heeren. | Information Technology Services | Chairman Founder Founder | |
Pulsify Medical BV
 Pulsify Medical BV Medical SpecialtiesHealth Technology Pulsify Medical BV is a Belgian digital medical technology company that specializes in developing wearable ultrasound patches. The company is based in Louvain, Belgium. Pulsify Medical was founded in 2019 by Lieven Herbots, Xavier Rottenberg, Jan D'hooge, Steve Stoffels. Iwan van Vijfeijken has been the CEO of the company since 2019. | Medical Specialties | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| België | 22 |
| Nederland | 7 |
| Duitsland | 6 |
| Verenigde Staten | 5 |
| Frankrijk | 5 |
Sectoraal
| Finance | 14 |
| Health Technology | 13 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Process Industries | 5 |
Operationeel
| Director/Board Member | 157 |
| Private Equity Investor | 47 |
| Chairman | 39 |
| Corporate Officer/Principal | 29 |
| Chief Executive Officer | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| Edwin Moses | 35 |
| George Gunn | 21 |
| Ekaterina Smirnyagina | 21 |
| Frank Bulens | 20 |
| Claude J. Stoufs | 17 |
| Hans Cobben | 14 |
| Rob van der Meij | 14 |
| Christian Petrus Goddelieve Lebeer | 14 |
| Jacques Vandermeiren | 14 |
| Paul Alfons Decraemer | 13 |
| Filip Goossens | 11 |
| Els Hubloux | 11 |
| Léon Cappaert | 10 |
| Katrin Geyskens | 10 |
| Stefan Dierckx | 9 |
- Beurs
- Insiders
- Ludwig Goris
- Bedrijfsconnecties
